A Case of Peritoneal Tuberculosis with Poncet's Disease in a Patient Treated with Infliximab
Journal of Rheumatic Diseases
;
: 55-59, 2011.
Article
in Korean
| WPRIM
| ID: wpr-104645
ABSTRACT
Infliximab is a chimeric mouse/human monoclonal antibody against tumor necrosis factor-alpha (TNF-alpha) that is used worldwide to treat rheumatic disease. However, the reactivation of tuberculosis, including extrapulmonary menifestation, is a severe side effect of anti-TNF-alpha treatment. Mycobacterium tubercluosis causes two forms of joint involvement, TB arthritis and Poncet's disease. Poncet's disease is a rare aseptic form of arthritis, known as reactive arthritis in tuberculosis. We encountered a case of tuberculous peritonitis with Poncet's disease in a 38-yearold man with a history of ankylosing spondylitis that was treated with infliximab. We report this case with a review of the literature.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Arthritis
/
Spondylitis, Ankylosing
/
Tuberculosis
/
Peritonitis, Tuberculous
/
Rheumatic Diseases
/
Tumor Necrosis Factor-alpha
/
Arthritis, Reactive
/
Infliximab
/
Joints
/
Antibodies, Monoclonal
Limits:
Humans
Language:
Korean
Journal:
Journal of Rheumatic Diseases
Year:
2011
Type:
Article
Similar
MEDLINE
...
LILACS
LIS